Next to alterations in renin–angiotensin–aldosterone system (RAAS) activity, brain morphological changes, i.e., an increased choroid plexus and reduced corpus callosum volume were observed in patients with low responsiveness to antidepressive therapy, which points to changes in barrier function in some forms of depression. The gene discussed is REN; the disease is depressive symptom measurement.